Review
Open access
Sep 2026
Benefit-Risk Balance for Medicinal Products: Report Summary from the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII.
By embedding structured, patient-centered BRA into lifecycle management, the CIOMS Working Group XII report provides a roadmap for transparent, evidence-based decisions that safeguard public health and optimize therapeutic outcomes.
S. Hill, Claudia Ana Ianos, L. Plouffe et al.
· Clinical Therapeutics · 0 citations